Plaintiffs are pushing back against an attempt by generic drug manufacturers and repackagers to dismiss ranitidine class action lawsuits filed over the risk of cancer from high levels of the chemical byproduct found in all versions of the heartburn drug, which was more commonly known by the brand name Zantac. Over the past year, ranitidine…
The findings of a new study highlight the consequences which may result from a delayed cancer diagnosis, indicating even a one month failure to detect cancer could be the difference between life and death for some patients. In a study published earlier this month in the medical journal The BMJ, Canadian researchers indicate even a…
In September 2019, the FDA warned that the popular heartburn drug Zantac may contain cancer-causing impurities. These same chemicals have been linked to an increased risk of colorectal cancer, stomach cancer, liver cancer and other health problems. STATUS OF ZANTAC LAWSUITS: Lawyers are investigating whether individuals diagnosed with cancer in recent years may be entitled to…
The findings of a new study appear to confirm that surgical breast implant removal is the best way to treat a rare type of cancer linked to the design of certain recalled products with a textured surface. Last year, Allergan was forced to issue worldwide breast implant recalls which impacted its entire line of “Biocell” macrotextured…
